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across the circumpolar regions
Annie-Claude Bourgeois1, Tammy Zulz2*, Bolette Soborg3 and
Anders Koch3 on behalf of the International Circumpolar Surveillance 
Tuberculosis Working Group
1Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON,
Canada; 2Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center
for Emerging and Zoonotic Diseases, Centers for Disease Control and Prevention, Anchorage, AK, USA;
3Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark
Background. Tuberculosis is highly prevalent in many Arctic areas. Members of the International
Circumpolar Surveillance Tuberculosis (ICS-TB) Working Group collaborate to increase knowledge about
tuberculosis in Arctic regions.
Objective. To establish baseline knowledge of tuberculosis surveillance systems used by ICS-TB member
jurisdictions.
Design. Three questionnaires were developed to reflect the different surveillance levels (local, regional and
national); all 3 were forwarded to the official representative of each of the 15 ICS-TB member jurisdictions in
2013. Respondents self-identified the level of surveillance conducted in their region and completed the
applicable questionnaire. Information collected included surveillance system objectives, case definitions, data
collection methodology, storage and dissemination.
Results. Thirteen ICS-TB jurisdictions [Canada (Labrador, Northwest Territories, Nunavik, Nunavut, Yukon),
Finland, Greenland, Norway, Sweden, Russian Federation (Arkhangelsk, Khanty-Mansiysk Autonomous
Okrug, Yakutia (Sakha Republic), United States (Alaska)] voluntarily completed the survey  representing
2 local, 7 regional and 4 national levels. Tuberculosis reporting is mandatory in all jurisdictions, and case
definitions are comparable across regions. The common objectives across systems are to detect outbreaks,
and inform the evaluation/planning of public health programmes and policies. All jurisdictions collect data
on confirmed active tuberculosis cases and treatment outcomes; 11 collect contact tracing results. Faxing of
standardized case reporting forms is the most common reporting method. Similar core data elements are
collected; 8 regions report genotyping results. Data are stored using customized programmes (n7) and
commercial software (n6). Nine jurisdictions provide monthly, bi-annual or annual reports to principally
government and/or scientific/medical audiences.
Conclusion. This review successfully establishes baseline knowledge on similarities and differences among
circumpolar tuberculosis surveillance systems. The similarity in case definitions will allow for description
of the epidemiology of TB based on surveillance data in circumpolar regions, further study of tuberculosis
trends across regions, and recommendation of best practices to improve surveillance activities.
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S
urveillance is a key component of efforts to control
and eradicate tuberculosis (TB) globally (1,2). While
a standardized approach to TB surveillance does not
exist, the World Health Organization (WHO) has put forth
a TB surveillance checklist of standards and benchmarks
in an attempt to help countries and regions identify gaps in
their current surveillance systems and bolster their ability
to attain accurate measures of annual TB cases and deaths
(3). Most jurisdictions however, even within a country,
have developed their own surveillance programmes based
on their unique infrastructure and needs as well as the
varied political interests, geography and resources for each
region (4). Variations across surveillance systems create
the potential for inconsistencies in data and thus present

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challenges when comparing data and trends across
regions/globally.
In 1999, the International Circumpolar Surveillance
(ICS) system was established by the Arctic Council’s
Sustainable Development Working Group to create an
infectious disease surveillance network throughout Arctic
jurisdictions (5). In 2006, ICS representatives from
Canada, Greenland and Alaska met to establish a TB
surveillance subgroup of the ICS network, as it was
recognized that TB continues to be a significant health
problem in the circumpolar region (6).
The circumpolar region comprises Greenland (that has
self-government but is part of the Danish Kingdom),
Iceland (as a sovereign country) and northern political-
administrative regions of countries including the United
States of America (USA), Canada, Norway, Sweden,
Finland, and the Russian Federation (7). For these areas,
health services are organized on either local, regional or
national levels. For the purpose of this review, all of these
areas are referred to as ‘‘jurisdiction’’ and are classified
according to their self-identified health system organiza-
tion (e.g. local jurisdiction).
To date, the ICS-TB Working Group includes jurisdic-
tional representatives from northern Canada, Finland,
Greenland, Norway, Sweden, Russian Federation and the
USA (Fig. 1). The mandate of ICS-TB is to increase
international knowledge on TB epidemiology-related issues
in the circumpolar region as well as to support further
epidemiologic projects and provide evidence to inform
policy decisions, programme design and evaluation in the
jurisdictions of the circumpolar region.
In order to accurately compare TB trends across
member jurisdictions and to establish baseline knowledge
on data recording and reporting, members of the ICS-
TB Working Group reviewed the TB surveillance systems
of ICS-TB jurisdictions. The goal of this project was to
describe the general characteristics of the different TB
surveillance systems used by ICS-TB jurisdictions to better
inform and support future data analyses. To the best of our
knowledge, this is the first descriptive review that compares
TB surveillance systems characteristics that focus solely on
circumpolar jurisdictions.
Methods
Questions were developed based on previously estab-
lished evaluation and component criteria of public health
surveillance systems (4,8,9). Three versions of a question-
naire were created to reflect the surveillance levels, local,
regional and national within the member jurisdictions.
We defined the surveillance levels as follows: a) A local
jurisdiction collects primary data on patients with diag-
nosed or suspected TB for a local health unit, TB clinics
and/or health care providers and the data are sent to
a secondary level of surveillance for collation, analysis
and so on. b) A regional jurisdiction receives data from
local jurisdictions where collation and analysis may be
performed with reporting back to the local level. Data are

















Fig. 1. Participating jurisdictions of the International Circumpolar Surveillance Tuberculosis Working Group.
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receives data from local and/or regional jurisdictions;
collation and analysis are performed and reporting may
be made back to the local and or regional level. Data
may be aggregated with other jurisdictions for national
reporting and reporting internationally, if applicable. The
number of questions varied from 31 (national) to 36 (local)
with 24 questions being identical in all 3 questionnaires.
The remaining questions were specific to each jurisdic-
tional level.
Questions were closed-ended, where possible, for better
comparability of the answers. Specific aspects investigated
included: a) activities and objectives, b) reporting activ-
ities, c) case identification methods, d) data collection,
e) data storage and f) data dissemination. The question-
naire outlined 6 main activities and objectives of TB
surveillance systems as proposed by the CDC on the uses
of surveillance data (8).
All participants also had the option to provide a flow
chart of their organizational structure or additional docu-
ments on their respective surveillance systems to comple-
ment the information provided in the questionnaire.
All 3 questionnaires were forwarded by electronic mail
to the official representative of each of the 15 ICS-TB
member jurisdictions. Participation in this project was
voluntary. The respondent was requested to identify the juri-
sdictional level that pertained to the surveillance system in
their region and complete the appropriate questionnaire.
Preliminary review of the completed questionnaires
revealed that some questions were interpreted differently
by the participants and that additional information was
needed for meaningful analysis and interpretation of the
questionnaire responses. The questionnaires were revised
and sent back to participants for their completion.
Results
Thirteen of the fifteen ICS-TB jurisdictions completed the
initial version of the questionnaire; of these 13, 12 returned
the revised version and 1 provided the additional informa-
tion by email. Two jurisdictions completed the question-
naires for ‘‘local’’ [Labrador and Yukon (Canada)], 7
for ‘‘regional’’ [Nunavik, Nunavut and Northwest Terri-
tory (Canada); Arkhangelsk, Khanty-Mansiysk Autono-
mous Okrug and Yakutia (Sakha Republic)  (Russian
Federation); and Alaska (USA)] and 4 for ‘‘national’’
(Finland, Greenland, Norway and Sweden). Nine jurisdic-
tions provided flow charts and/or additional comments or
documents (Alaska, Arkhangelsk, Finland, Greenland,
Khanty-Mansiysk Autonomous Okrug, Northwest Terri-
tories, Nunavik, Sweden and Yukon).
Definitions of active TB cases were comparable across
the 13 jurisdictions; 5 use the WHO standards (10) and
8 use slightly modified WHO standards. Briefly, a case of
active TB is deemed laboratory confirmed if Mycobac-
terium tuberculosis complex (M. tuberculosis, M. bovis,
M. africanum, M. canetti and M. microti) is demonstrated
on culture or by newer methods such as molecular line
probe assay or a sputum specimen positive for acid-fast
bacilli. In participating jurisdictions, a clinically diagnosed
or probable case refers to a case for which, in absence of
bacteriological proof, there were either chest radiographic
changes compatible with active TB and/or treatment has
been initiated. All jurisdictions identify active cases
through laboratory confirmation and/or clinical diagnosis
by chest X-ray (Nunavik and Alaska also require compa-
tible clinical signs with a positive X-ray). National report-
ing systems allow for the determination of whether a case
is new or relapsed as a result of previous treatment failure,
consistent with the WHO definitions for 3 regions. This
information was not available for 1 jurisdiction.
All 13 jurisdictions reported outbreak identification and
control, informing programme planning and policy devel-
opment, and contributing to the evaluation of public
health programmes and policies as the main objectives
and activities of their TB surveillance systems. Most,
but not all, reported that the additional (secondary)
objectives of the surveillance systems were: scientific and
research purposes (except Labrador, Yukon and Khanty-
Mansiysk); generating and maintaining public awareness
(except Khanty-Mansiysk); and conducting evaluations to
identify gaps and areas of improvement (except Khanty-
Mansiysk). For the 4 national systems, TB surveillance
systems were designed to meet all 6 objectives and activities
listed in the questionnaire.
All TB surveillance systems in the participating jur-
isdictions are centralized and publically funded. Reporting
of laboratory-confirmed active TB cases and treatment
outcome is mandatory in all jurisdictions (Table I).
Clinically diagnosed cases are reported in 11 jurisdictions
(85%). Contact screening results were reportable in all
jurisdictions except for Sweden and Finland. Latent TB
infection (LTBI) is reportable in 6 (46%) local or regional
jurisdictions; in 2 jurisdictions, LTBI is reportable in the
context of contact screening only; in 4 jurisdictions, LTBI
is reportable regardless of the reason for screening.
However, treatment outcomes of LTBI are reportable
in 8 (62%) of the jurisdictions, including 1 national
(Greenland); of note, LTBI is reportable in some jurisdic-
tions only when prophylactic treatment is initiated.
The estimated proportion of active TB cases reported
ranged from 75 to 100% (Table II). All jurisdictions collect
case-level data using standardized reporting forms with
supporting guidelines and/or data dictionary; 2 regional
and 1 national jurisdiction also collect aggregated data
(Khanty-Mansiysk, Nunavik and Norway). Data are
received using one or multiple data submission methods
including electronic submissions that feed into the TB sur-
veillance database (n5; 42%), faxing (n8; 62%), emails
(n4; 33%), postal mail (n7; 54%) or email consultations
from clinicians on cases and/or contacts (n1; 8%). Of all
jurisdictions, only 3 of them, Arkhangelsk, Greenland and
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Table I. Surveillance system characteristics and tuberculosis reporting elements for each jurisdiction
























Local Labrador  X X X X X X X X
Yukon 2004 X X X X  X X X
Regional Khanty-Mansiysk
Autonomous Okrug
1998  X  X   X X
Arkhangelsk 1998  X  X X X X X
Yakutia 2005 X X  X   X X
Nunavik 1990 X X  X X   X
Northwest
Territories
 X X X X X X X X
Nunavut 1999 X X X X X  X X
Alaska 1950’s X X X X    X
National Greenland 1956 X X  X   X X
Sweden 1940 X X  X    
Finland 1995 X X  X    
Norway 1962 X X X X    X
aIndividuals with a positive Tuberculin Skin Test (TST) and/or IGRA result  In the context of contact screening only.
bRegardless of the reason for screening.







































































































Sweden, rely solely on electronic submissions (Table II).
All local and regional jurisdictions, except Alaska, are
provided with a standardized form for data reporting to
higher jurisdictional levels. Local jurisdictions report
either weekly or on an ad hoc basis to their regional
offices, and regional jurisdictions mainly report to the
national level on an annual basis.
Core data elements reported within the TB surveillance
systems are similar across jurisdictions, including demo-
graphic information, laboratory results, chest X-ray or
computerized tomography (CT) scan (except Finland),
PCR test results (except Khanty-Mansiysk) and drug-
resistance test results (except Khanty-Mansiysk). Geno-
typing test results such as mycobacterial interspersed
repetitive units (MIRU) or spoligotype are reported in
Labrador, Yukon, Nunavik, Nunavut, Alaska and all 4
national jurisdictions.
Usually only positive laboratory results are reported,
but for 4 jurisdictions (Arkhangelsk, Khanty-Mansiysk
Autonomous Okrug, Yakutia and Finland) both negative
and positive laboratory results (smear and culture) are
communicated to these jurisdictional TB surveillance
programmes. Risk factors, social determinants of health
and/or co-morbidity for active cases are collected in 9
jurisdictions (69%), with Norway being the only national
jurisdiction collecting such information. Testing for hu-
man immunodeficiency virus (HIV) status for all active
TB cases is done or requested in all local and regional
jurisdictions except Nunavut and 1 national jurisdiction
(Norway). When available, results are reported directly
to the TB surveillance programme in those jurisdictions
(except Nunavik). Although testing and results are not
reported directly to the TB programme in Finland, there is
cross-matching between the HIV and TB databases.
Social determinants of health, such as data on home-
lessness, incarceration, smoking status, substance abuse,
steroid use, diabetes diagnosis and others, are collected
in all local and regional jurisdictions except Nunavut and
1 national jurisdiction (Norway).
Data are stored using commercial software such as
Microsoft ExcelTM or AccessTM (n6; 46%) and/or in-house/
customized programmes (n7; 54%) (Table II). Four
regional jurisdictions (31%) also maintain paper-based
records in addition to an electronic system; when writing
this article, Alaska was transitioning from a completely
paper-based system to a customized electronic system.
Table II. Data collection and storage for surveillance systems
Jurisdictions
Estimated % of all TB
cases captured by system
Case submission
methods Method of storage Data accessible to others
Local Labrador 100 Electronic to
database, fax
Commercial software No





100 Fax, mail Commercial software,
paper-based
Available upon request
Arkhangelsk 9598 Electronic to
database
In-house/custom software Partial access
Yakutia 100 Fax, mail In-house/custom software Available upon request





80 Email, fax, mail In-house/custom
software, paper-based
Available upon request
Nunavut 100 Email, fax, mail Commercial software,
paper-based
No
Alaska 100 Email, fax, mail In-house/custom
software, paper-based
Available upon request
National Greenland 75 Electronic to
database
Commercial software No
Sweden 95100 Electronic to
database
In-house/custom software Available upon request
Finland 95 Electronic to
database, mail
In-house/custom software Available upon request,
available online, partial
access
Norway 100 Mail In-house/custom software Available upon request,
available online
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A unique case identifier number for active TB cases is used
in all jurisdictions. In both local jurisdictions (Labrador
and Yukon), contact tracing information is collected by
paper form. In Yukon, this information is also captured
in a computerized database that is not linked to the TB
surveillance database. Detection for discrepancies and
duplicates in the database is performed for all TB
surveillance systems, and these data verification functions
are performed automatically (e.g. prompting alert) and/or
manually (Greenland only). Data on TB cases, either line-
listed and/or aggregated, are available to the public from
most jurisdictions, either online (n3; 23%) and/or upon
request (n7; 54%) (Table II).
Reports using TB surveillance data are produced by all
jurisdictions except Yukon (n11, 92%) mainly annually
(n8; 62%) and/or on an ad hoc basis (n6; 46%). Of
those jurisdictions disseminating data, report audiences
are government(s) (n12/12; 100%), the scientific/med-
ical community (n9/12; 75%), and/or the general public
(n8/12; 66%).
Discussion
To our knowledge, this is the first review of the general
characteristics, similarities and differences of TB surveil-
lance systems across circumpolar jurisdictions. A similar
review of TB surveillance systems was conducted by Mor
et al. (4); however, the review focused on low-incidence
industrialized countries in Western Europe, the USA,
Canada, Australia and New Zealand. Across all surveyed
circumpolar jurisdictions, surveillance of TB is a deep-
rooted activity of the public health system; reporting of
active TB cases and their respective treatment outcome is
mandatory in each ICS-TB jurisdiction, aligned with the
WHO recommendations, with reporting completeness
estimated (by the jurisdictions themselves) to be close
to 100%. In addition, and regardless of the surveillance
level, all systems are centralized and publically funded.
System descriptions
Thirteen ICS-TB jurisdictions participated in this project,
representing 7 countries in, or with partial geographical
area in the circumpolar region. There are notable differ-
ences among the jurisdictions participating to ICS-TB in
terms of resources, geography and social determinants
of health that may affect the efficacy of a TB programme
and related surveillance system (11). However, influential
factors across jurisdictions outside of TB surveillance
systems (e.g. financial resources, remoteness and housing
shortages resulting in overcrowding) were not investigated
in the survey, and therefore, comments on the impacts
of those factors on a TB surveillance system cannot be
assessed.
Case definitions
Although there were slight variations in the definitions
provided for active TB cases or in the terminology (e.g.
clinically confirmed versus probable cases), identical
components were found in all definitions and aligned
with the WHO definitions (9). In addition, most of the
core data elements collected by the jurisdictions for active
TB cases and their resulting treatment outcome are similar
and captured in a standardized way via forms. Those
similarities allow for the development of harmonized
definitions among the ICS-TB jurisdictions for further
description of the epidemiology of TB and trends in the
circumpolar region.
The purpose of a public health surveillance system
varies depending on the public health needs and roles
of a defined jurisdiction (8). In all the ICS-TB jurisdic-
tions, the TB surveillance systems’ objectives go beyond
and above case management, outbreak identification and
disease monitoring, and are linked to programme and
policy planning, development and evaluation as reports
produced by the jurisdictions target governmental and
scientific audiences (1214). In this era of globalization,
and with this goal in mind, there is a potential for the ICS-
TB jurisdictions to consider providing recommendations
to improve TB surveillance in circumpolar regions.
Contact tracing and LTBI
A common practice in TB control and prevention is
to conduct contact tracing for active cases in order to
identify and treat TB-infected contacts (1517). Despite
the challenges faced by most of the circumpolar regions
(e.g. limited staff and financial resources), local TB
programmes in the ICS-TB jurisdictions and some regio-
nal programmes from low-density populations, such
as Nunavik, Northwest Territories and others, collect
results and information on LTBI and/or contact tracing
to ensure appropriate case management and better out-
break prevention. LTBI reporting and monitoring appear
to be a lower priority at the national level, as only
Greenland collects information (and in this jurisdiction,
LTBI is reportable only when isoniazid preventive therapy
is initiated). National level interest in collecting LTBI
and contact information was not included in this survey;
however, given the current WHO recommendations to-
wards TB elimination, there is likely to be increased focus
on LTBI monitoring in the future (18).
Social determinants, risk factors and co-morbidities
The collection of information on social determinants of
health, risk factors and co-morbidities for TB (e.g. home-
lessness, incarceration, smoking status, substance abuse,
steroid use, diabetes and HIV) resides mainly in the local
and regional circumpolar jurisdictions; however, whether
this information was reported to a higher level (i.e.
at regional or country level) for those regions was not
assessed. None of the ICS-TB national jurisdictions collect
those elements, with the exception of Norway where
some information on HIV is gathered. In some cases,
this information may possibly be captured in different
Annie-Claude Bourgeois et al.
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registries linked with the TB surveillance database (4),
such as Greenland. The impact of previously identified
risk factors for TB and co-morbidities such as HIV or
diabetes in the circumpolar region (19,20) may be esti-
mated through this collaboration and may further support
programme and policy planning in those jurisdictions.
Drug resistance
As drug resistant TB has become a global concern and
public health priority, monitoring of emerging trends
and patterns in anti-tuberculosis drug resistance is a key
activity in TB control (3,21). Drug-resistance testing of
TB isolates is done across all ICS-TB jurisdictions, and
laboratory results are all reported directly from the
laboratory to the TB surveillance programme (except
Khanty-Mansiysk), therefore reducing the likelihood of
errors due to a multilayered reporting system.
Electronic reporting systems
With computerized technology becoming more available,
online reporting systems are being developed and cur-
rently 5 ICS-TB jurisdictions, including 3 national ones,
have an online reporting system directly linked to the TB
surveillance system. Fax remains the most common way of
submitting data, but data still need to be entered manually
in the electronic database, which increases the likelihood
of transcription mistakes and is a time consuming process.
However, some jurisdictions have overcome these chal-
lenges  Greenland has an electronic reporting system
despite the remoteness of most of its communities. The
experience and lessons learned on TB surveillance and
database development from ICS-TB jurisdictions sharing
similar characteristics may be of use to provide recom-
mendations to other ICS-TB regions wishing to move
towards electronic submission.
Limitations
Our study includes some limitations that may affect
the interpretation of the results. Each jurisdiction self-
identified the appropriate reporting level. Although defi-
nitions were provided for the 3 levels, there may be
discrepancies in the self-identification process and selec-
tion of the appropriate survey. This survey included only
ICS-TB member jurisdictions and was not extended to
circumpolar jurisdictions outside of the working group,
which may have differences in their TB surveillance
systems structure and processes. Comparisons were also
made from various levels of reporting, regardless of the
differences in resources (human, national gross income,
etc.), geography and technical and technological capaci-
ties; therefore, the interpretation of some results should
be made with caution. The questionnaires were not
designed to evaluate attributes of the TB surveillance
systems or databases (such as data quality, sensitivity or
timeliness), and therefore, it is not possible to make system
recommendations or to comment on the impacts of
incorporating changes in a given surveillance system.
This study was cross-sectional, focusing only on the
TB surveillance systems and did not take into considera-
tion the progression, improvements or challenges (e.g.
resources) of the different surveillance systems and TB
programme structures over time.
Conclusion
Similarities and differences among the circumpolar TB
surveillance systems highlighted in this review establish
baseline knowledge on data recording and reporting
of ICS-TB member jurisdictions and will allow for the
contextualization of TB trends across jurisdictions.
Although case definitions are similar and consistent with
the WHO standards, it will allow for the description of
the epidemiology of TB on multilevel surveillance data
in circumpolar region and further study of TB trends
across regions. Furthermore, the information collected in
the survey will serve to guide further discussion within the
ICS-TB working group to make recommendations on best
practices to improve surveillance activities in circumpolar
regions.
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